Cargando…
Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
Insulin receptor substrate 2 (IRS2) is a key downstream mediator of insulin and insulin-like growth factor 1 (IGF1) signalling pathways and plays a major role in liver metabolism. The aim of this study was to investigate whether IRS2 had an impact on the hepatic fibrotic process associated with chol...
Autores principales: | Villar-Lorenzo, Andrea, Rada, Patricia, Rey, Esther, Marañón, Patricia, Arroba, Ana I., Santamaría, Beatriz, Sáiz, Jorge, Rupérez, Francisco J., Barbas, Coral, García-Monzón, Carmelo, Valverde, Ángela M., González-Rodríguez, Águeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679376/ https://www.ncbi.nlm.nih.gov/pubmed/31262748 http://dx.doi.org/10.1242/dmm.038810 |
Ejemplares similares
-
Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
por: Rey, Esther, et al.
Publicado: (2021) -
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
por: Rada, Patricia, et al.
Publicado: (2020) -
Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice
por: González-Rodríguez, Águeda, et al.
Publicado: (2010) -
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022) -
Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36
por: Rey, Esther, et al.
Publicado: (2020)